Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Breast Cancer by Letrozole in Post-menopausal Women Carrying a BRCA1/BRCA2 Mutation

NCT00673335 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT00673335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00673335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Breast Cancer by Letrozole in Post-menopausal Women Carrying a BRCA1/BRCA2 Mutation
Lead sponsor
UNICANCER
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2008
Completion date
December 31, 2023
Enrollment
170 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 mutation carrier, brca2 mutation carrier, breast cancer, hereditary breast/ovarian cancer (brca1, brca2)